ArticleJHEP reports : innovation in hepatology2023

Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B.

Young-Suk Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.